Klacid

Clarithromycin, the active ingredient in Klacid, is a macrolide antibiotic presented as an oral tablet for oral use. It treats bacterial infections such as community‑acquired pneumonia, acute bacterial sinusitis, and skin infections in adults and children when prescribed by a healthcare professional.

GNH USA supplies Klacid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution, including compliance with EU GMP guidelines and traceability throughout the supply chain.

Clarithromycin is a macrolide antibiotic used to treat infections of the respiratory and skin pathways. - Community‑acquired pneumonia: effective in eradicating the typical bacterial pathogens causing the infection. - Acute bacterial sinusitis: reduces symptoms and clears the sinus infection. - Acute exacerbations of chronic bronchitis: shortens the duration of bacterial flare‑ups. - Skin and soft‑tissue infections: treats cellulitis and other bacterial skin conditions. - Helicobacter pylori eradication (in combination therapy): contributes to successful bacterial clearance when used with other agents.

Clarithromycin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: transient upset stomach often occurring after the first dose. - Diarrhea: loose stools that may be watery or mild. - Abdominal pain: cramping or discomfort in the stomach region. - Taste disturbance: altered or metallic taste perception. - Headache: mild to moderate headache episodes. - Vomiting: occasional emesis, especially with higher doses.

Serious or Rare Side Effects: - Severe allergic reactions: rash, itching, swelling, or anaphylaxis. - Clostridioides difficile‑associated diarrhea: severe colitis requiring medical attention. - Liver enzyme elevation: potential hepatotoxicity indicated by increased transaminases. - QT interval prolongation: risk of cardiac arrhythmias in susceptible individuals. - Myocardial arrhythmias: irregular heartbeats that may be life‑threatening. - Anaphylaxis: rapid onset of systemic hypersensitivity requiring emergency care.

Before prescribing Klacid, clinicians should evaluate patient‑specific factors and monitor for potential complications. - Assess renal function: adjust use in severe renal impairment. - Monitor liver enzymes: use with caution in hepatic disease. - Avoid in known macrolide hypersensitivity: discontinue if allergic reaction occurs. - Review concomitant medications: consider interaction potential. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture and light.

Clarithromycin can alter the plasma concentrations of several co‑administered drugs, requiring careful management.

Major Interactions (Avoid): - Cisapride: may cause life‑threatening arrhythmias. - Ergot alkaloids: risk of severe vasospasm and ergotism. - Pimozide: can lead to markedly increased plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: may increase INR; monitor coagulation parameters. - Oral contraceptives: may reduce hormonal efficacy; advise additional contraception.